Interferon Subtype Expression
Interferon Subtype Expression - Related Videos
10:00
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
0 Views •
Cited by 2 •
2015
This protocol describes a high-throughput qRT-PCR assay for the analysis of type I and III IFN expression signatures. The assay discriminates single base pair differences between the highly similar transcripts of these genes. Through batch assembly and robotic pipetting, the assays are consistent and reproducible.
14:40
Expression Analysis of Mammalian Linker-histone Subtypes
0 Views •
Cited by 22 •
2012
We describe a set of assays to analyze expression levels of H1 linker histones. mRNA of individual H1 genes are quantitatively measured by random primer based reverse transcription followed by real-time PCR, whereas protein quantification of H1 histones is achieved by HPLC analysis.
06:42
Subtype-selective Electroporation of Cortical Interneurons
0 Views •
Cited by 13 •
2014
This procedure shows how to target interneurons in the developing mouse forebrain by means of in utero electroporation. This technique was particularly efficient to achieve selective gene expression in interneuron subtypes destined to the superficial layers of the cortex.
03:11
Quantification of Bioactive Type-I Interferons using a Secreted Embryonic Alkaline Phosphatase Reporter Assay
0 Views •
2025
This video demonstrates secreted embryonic alkaline phosphatase assay using HEK-Blue interferon-α/β reporter cells to quantify the type-I interferons (IFNs) released following stimulation of plasmacytoid dendritic cells by HIV-1 Infected CD4+ T cells.
02:17
An In Vitro Assay for Screening Interferons as Potent Inhibitors of Zika Virus Growth
0 Views •
2025
The video demonstrates an in vitro assay for screening interferons with antiviral activity against the Zika virus, a human pathogen. Within the host cell, the Zika virus undergoes multiplication upon internalization, infecting neighboring cells and creating distinct zones or viral plaques. Type I interferon, acting as an antiviral agent, hinders virus multiplication, thereby preventing the formation of viral plaques in the host cell monolayer.
FAQs
Distinct interferon subtypes bind specific receptors, which initiates JAK-STAT signaling in responsive cells. This pathway regulates interferon-stimulated genes, linking subtype production to changes in antiviral and immune activity. Because receptor engagement and downstream gene regulation determine the cellular response, comparing subtypes can reveal why otherwise similar interferon signals produce different effects during infection.
These sensor systems detect pathogen-associated molecular patterns and activate transcription of interferon genes. Their activation provides an upstream connection between infection and the production of particular interferon subtypes. Examining which sensing pathways accompany subtype expression can help explain how cells initiate antiviral responses and why expression patterns may vary between infectious conditions.
Expression patterns can change with the infected tissue, the responding cell type, and the stage of disease. These differences indicate that interferon responses are coordinated according to biological context rather than produced uniformly throughout an infection. Comparing these variables helps identify where particular subtypes are expressed and how immune protection changes as disease progresses.
Subtype-specific receptor binding connects individual interferons to downstream JAK-STAT signaling and interferon-stimulated gene regulation. This relationship helps distinguish the presence of an interferon response from the particular signaling program it produces. In infection studies, that distinction can clarify why one subtype profile may support antiviral activity while another may be associated with different immune consequences.
A comparison should separate samples by infected tissue, cell type, and disease stage, then examine the interferon subtype patterns observed in each group. Relating these profiles to the infection context can reveal coordinated or contrasting responses across biological settings. This approach is useful for identifying stage-specific changes and determining whether expression patterns are consistent across tissues or cell populations.
Subtype expression profiles can provide indicators of how an infection is affecting particular tissues, cell types, or disease stages. When consistently associated with these contexts, such patterns may support biomarker development and improve interpretation of immune activity. The value comes from comparing expression across conditions rather than treating total interferon activity as a single, uniform measurement.
Therapy studies can use subtype expression patterns to examine whether treatment is associated with antiviral immune activity and how responses vary across infection contexts. They can also help assess the balance between antiviral protection and inflammatory tissue damage. This makes subtype analysis relevant not only to therapeutic activity, but also to understanding potentially undesirable immune consequences.